Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers.

Nigro A, Montico B, Casolaro V, Dal Col J.

Methods Mol Biol. 2019;1884:317-333. doi: 10.1007/978-1-4939-8885-3_22.

PMID:
30465213
2.

Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development.

Montico B, Nigro A, Casolaro V, Dal Col J.

Int J Mol Sci. 2018 Feb 16;19(2). pii: E594. doi: 10.3390/ijms19020594. Review.

3.

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy.

Montico B, Lapenta C, Ravo M, Martorelli D, Muraro E, Zeng B, Comaro E, Spada M, Donati S, Santini SM, Tarallo R, Giurato G, Rizzo F, Weisz A, Belardelli F, Dolcetti R, Dal Col J.

Oncoimmunology. 2017 Jul 31;6(11):e1356964. doi: 10.1080/2162402X.2017.1356964. eCollection 2017.

4.

Alteration of Nrp1 signaling at different stages of olfactory neuron maturation promotes glomerular shifts along distinct axes in the olfactory bulb.

Assens A, Dal Col JA, Njoku A, Dietschi Q, Kan C, Feinstein P, Carleton A, Rodriguez I.

Development. 2016 Oct 15;143(20):3817-3825. Epub 2016 Aug 30.

5.

Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma.

Mastorci K, Montico B, Faè DA, Sigalotti L, Ponzoni M, Inghirami G, Dolcetti R, Dal Col J.

Oncotarget. 2016 Jul 5;7(27):41913-41928. doi: 10.18632/oncotarget.9630.

6.

Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy.

Faè DA, Martorelli D, Mastorci K, Muraro E, Dal Col J, Franchin G, Barzan L, Comaro E, Vaccher E, Rosato A, Dolcetti R.

Cancer Immunol Res. 2016 May;4(5):431-40. doi: 10.1158/2326-6066.CIR-15-0108. Epub 2016 Mar 23.

7.

A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.

Martorelli D, Muraro E, Mastorci K, Dal Col J, Faè DA, Furlan C, Giagulli C, Caccuri F, Rusnati M, Fiorentini S, Carbone A, Caruso A, Dolcetti R.

Int J Cancer. 2015 Sep 15;137(6):1374-85. doi: 10.1002/ijc.29494. Epub 2015 Mar 9.

8.

Epstein-Barr virus and telomerase: from cell immortalization to therapy.

Dolcetti R, Giunco S, Dal Col J, Celeghin A, Mastorci K, De Rossi A.

Infect Agent Cancer. 2014 Feb 26;9(1):8. doi: 10.1186/1750-9378-9-8.

9.

Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

Dolcetti R, Dal Col J, Martorelli D, Carbone A, Klein E.

Semin Cancer Biol. 2013 Dec;23(6):441-56. doi: 10.1016/j.semcancer.2013.07.005. Epub 2013 Aug 3. Review.

PMID:
23917255
10.

hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.

Giunco S, Dolcetti R, Keppel S, Celeghin A, Indraccolo S, Dal Col J, Mastorci K, De Rossi A.

Clin Cancer Res. 2013 Apr 15;19(8):2036-47. doi: 10.1158/1078-0432.CCR-12-2537. Epub 2013 Feb 26.

11.

NFATc2 is a potential therapeutic target in human melanoma.

Perotti V, Baldassari P, Bersani I, Molla A, Vegetti C, Tassi E, Dal Col J, Dolcetti R, Anichini A, Mortarini R.

J Invest Dermatol. 2012 Nov;132(11):2652-60. doi: 10.1038/jid.2012.179. Epub 2012 Jun 21.

12.

Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets.

Dal Col J, Mastorci K, Faè DA, Muraro E, Martorelli D, Inghirami G, Dolcetti R.

Cancer Res. 2012 Apr 1;72(7):1825-35. doi: 10.1158/0008-5472.CAN-11-2505. Epub 2012 Feb 6.

13.

The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells.

Trotta R, Ciarlariello D, Dal Col J, Mao H, Chen L, Briercheck E, Yu J, Zhang J, Perrotti D, Caligiuri MA.

Blood. 2011 Feb 24;117(8):2378-84. doi: 10.1182/blood-2010-05-285130. Epub 2010 Dec 14.

14.
15.

TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.

Trotta R, Dal Col J, Yu J, Ciarlariello D, Thomas B, Zhang X, Allard J 2nd, Wei M, Mao H, Byrd JC, Perrotti D, Caligiuri MA.

J Immunol. 2008 Sep 15;181(6):3784-92.

16.

Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.

Terrin L, Dal Col J, Rampazzo E, Zancai P, Pedrotti M, Ammirabile G, Bergamin S, Rizzo S, Dolcetti R, De Rossi A.

J Virol. 2008 Oct;82(20):10175-87. doi: 10.1128/JVI.00321-08. Epub 2008 Aug 6.

17.

Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma.

Dal Col J, Zancai P, Terrin L, Guidoboni M, Ponzoni M, Pavan A, Spina M, Bergamin S, Rizzo S, Tirelli U, De Rossi A, Doglioni C, Dolcetti R.

Blood. 2008 May 15;111(10):5142-51. doi: 10.1182/blood-2007-07-103481. Epub 2008 Mar 13.

PMID:
18339899
18.

The PP2A inhibitor SET regulates natural killer cell IFN-gamma production.

Trotta R, Ciarlariello D, Dal Col J, Allard J 2nd, Neviani P, Santhanam R, Mao H, Becknell B, Yu J, Ferketich AK, Thomas B, Modi A, Blaser BW, Perrotti D, Caligiuri MA.

J Exp Med. 2007 Oct 1;204(10):2397-405. Epub 2007 Sep 17.

19.

hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.

Terrin L, Dolcetti R, Corradini I, Indraccolo S, Dal Col J, Bertorelle R, Bonaldi L, Esposito G, De Rossi A.

Int J Cancer. 2007 Aug 1;121(3):576-87.

20.

Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins.

Zancai P, Dal Col J, Piccinin S, Guidoboni M, Cariati R, Rizzo S, Boiocchi M, Maestro R, Dolcetti R.

Oncogene. 2005 Apr 7;24(15):2483-94.

PMID:
15735731
21.

Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma.

Guidoboni M, Zancai P, Cariati R, Rizzo S, Dal Col J, Pavan A, Gloghini A, Spina M, Cuneo A, Pomponi F, Bononi A, Doglioni C, Maestro R, Carbone A, Boiocchi M, Dolcetti R.

Cancer Res. 2005 Jan 15;65(2):587-95.

Supplemental Content

Loading ...
Support Center